Suppr超能文献

开发一种高效的单细胞克隆和扩增策略,用于基因组编辑诱导的多能干细胞。

Development of an efficient single-cell cloning and expansion strategy for genome edited induced pluripotent stem cells.

机构信息

CSIR Institute of Genomics and Integrative Biology, Mathura Road, Sukhdev Vihar, New Delhi, India.

Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.

出版信息

Mol Biol Rep. 2022 Aug;49(8):7887-7898. doi: 10.1007/s11033-022-07621-9. Epub 2022 May 30.

Abstract

BACKGROUND

Disease-specific human induced pluripotent stem cells (hiPSCs) can be generated directly from individuals with known disease characteristics or alternatively be modified using genome editing approaches to introduce disease causing genetic mutations to study the biological response of those mutations. The genome editing procedure in hiPSCs is still inefficient, particularly when it comes to homology directed repair (HDR) of genetic mutations or targeted transgene insertion in the genome and single cell cloning of edited cells. In addition, genome editing processes also involve additional cellular stresses such as poor cell viability and genetic stability of hiPSCs. Therefore, efficient workflows are desired to increase genome editing application to hiPSC disease models and therapeutic applications.

METHODS AND RESULTS

To this end, we demonstrate an efficient workflow for feeder-free single cell clone generation and expansion in both CRISPR-mediated knock-out (KO) and knock-in (KI) hiPSC lines. Using StemFlex medium and CloneR supplement in conjunction with Matrigel cell culture matrix, we show that cell viability and expansion during single-cell cloning in edited and unedited cells is significantly enhanced. Keeping all factors into account, we have successfully achieved hiPSC single-cell survival and cloning in both edited and unedited cells with rates as maximum as 70% in less than 2 weeks.

CONCLUSION

This simplified and efficient workflow will allow for a new level of sophistication in generating hiPSC-based disease models to promote rapid advancement in basic research and also the development of novel cellular therapeutics.

摘要

背景

疾病特异性的人类诱导多能干细胞(hiPSCs)可以直接从具有已知疾病特征的个体中产生,或者通过基因组编辑方法进行修饰,引入致病基因突变,以研究这些突变的生物学反应。hiPSCs 中的基因组编辑过程仍然效率低下,特别是在同源定向修复(HDR)基因突变或基因组中靶向转基因插入和编辑细胞的单细胞克隆时。此外,基因组编辑过程还涉及其他细胞应激,如 hiPSCs 的细胞活力差和遗传稳定性。因此,需要高效的工作流程来增加基因组编辑在 hiPSC 疾病模型和治疗应用中的应用。

方法和结果

为此,我们展示了一种在 CRISPR 介导的敲除(KO)和敲入(KI)hiPSC 系中进行无饲养细胞单细胞克隆生成和扩增的高效工作流程。使用 StemFlex 培养基和 CloneR 补充剂以及 Matrigel 细胞培养基质,我们表明,在编辑和未编辑细胞的单细胞克隆过程中,细胞活力和扩增显著增强。考虑到所有因素,我们已经成功地实现了 hiPSC 单细胞的生存和克隆,在编辑和未编辑细胞中的存活率最高可达 70%,不到 2 周。

结论

这种简化和高效的工作流程将为基于 hiPSC 的疾病模型的生成带来新的水平,促进基础研究的快速进展,也为新型细胞治疗的发展提供帮助。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验